Pfizer isn’t stopping to smell the roses on its speed run to secure a full FDA approval for its Braftovi combination therapy. After securing a unique accelerated approval not quite six months ago, the ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Matthew Herper covers medical innovation — both its promise and its perils. Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall ...

ASCO and Google Cloud launched an AI tool to streamline access to evidence-based clinical guidelines, addressing oncologists' time constraints. The ASCO Guidelines Assistant uses Google Cloud's Vertex ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. In this episode of Meeting Mic, we bring you pearls and ...

This story has been updated with expert comments. The American Society of Clinical Oncology (ASCO) and Google Cloud have recently launched an artificial intelligence (AI)–powered search tool to ...

Bispecific antibodies are one of the most active areas of cancer research, and pharmaceutical companies are busy striking deals to add them to their pipelines. One of the most talked about drugs at ...